Clinical Implications of Anti-CD19 Chimeric Antigen Receptors (CAR) T Cell Therapy in Acute Lymphoblastic Leukemia (ALL)

Ali R Jazirehi^1*, Tam N M Dinh¹, Zena Taraporewalla¹, Jahzeel L Paguntalan¹ and Gary J Schiller²

¹Division of Surgical Oncology, Department of Surgery, University of California, Los Angeles, USA

²Division of Hematology/Oncology, Department of Medicine, The Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, University of California, Los Angeles, USA

^*Corresponding Author: Ali R Jazirehi, Division of Surgical Oncology, Department of Surgery, University of California, Los Angeles, USA Email: